Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Loriot

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Clinical Pharmacology and Therapeutics|September 17, 2013
A case of 5-FU-related severe toxicity associated with the p.Y186C DPYD variantA Zaanan, L-M Dumont, M-A Loriot, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistanceL Bodin, M H Horellou, C Flaujac, et al.
Pharmacogenetics|February 24, 2001
Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDSP Wolkenstein, M A Loriot, S Aractingi, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|September 30, 1998
[Characterization of liver regeneration in the albumin-urokinase transgenic mouse]J Nicolet, M A Loriot, E Bonte, et al.
Transplantation Proceedings|November 22, 2011
Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriersS Fougeray, M-A Loriot, V Nicaud, et al.
Pathologie-Biologie|December 4, 2012
Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G>A of the VKORC1 gene; On acenocoumarol requirement in Moroccan patientsF Z Smires, R Habbal, C Moreau, et al.
La Revue De Medecine Interne|March 23, 2023
[Clinical, biochemical and epidemiological features of macro-AST preceding inflammatory bowel disease diagnosis by several years]Z Nadour, B Rosenbaum, H Blons, et al.
Digestive Diseases and Sciences|November 21, 1998
Concurrent emergence of hepatitis B e antigen-negative hepatitis B virus variant and autoimmune hepatitis cured by adenine arabinoside monophosphateH Bécheur, D Valla, M A Loriot, et al.
Hepatology (Baltimore, Md.)|July 10, 1998
Hepatitis C virus persistence in human hematopoietic cells injected into SCID miceJ P Bronowicki, M A Loriot, V Thiers, et al.
Journal of Hepatology|July 1, 1990
Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis?P Marcellin, E Giostra, N Boyer, et al.
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Clinical Pharmacology and Therapeutics|September 17, 2013
A case of 5-FU-related severe toxicity associated with the p.Y186C DPYD variantA Zaanan, L-M Dumont, M-A Loriot, et al.
Journal of Thrombosis and Haemostasis : JTH|June 28, 2005
A vitamin K epoxide reductase complex subunit-1 (VKORC1) mutation in a patient with vitamin K antagonist resistanceL Bodin, M H Horellou, C Flaujac, et al.
Pharmacogenetics|February 24, 2001
Prospective evaluation of detoxification pathways as markers of cutaneous adverse reactions to sulphonamides in AIDSP Wolkenstein, M A Loriot, S Aractingi, et al.
Chirurgie; Memoires De L'Academie De Chirurgie|September 30, 1998
[Characterization of liver regeneration in the albumin-urokinase transgenic mouse]J Nicolet, M A Loriot, E Bonte, et al.
Transplantation Proceedings|November 22, 2011
Increased body mass index after kidney transplantation in activating transcription factor 6 single polymorphism gene carriersS Fougeray, M-A Loriot, V Nicaud, et al.
Pathologie-Biologie|December 4, 2012
Effect of different genetics variants: CYP2C9*2, CYP2C9*3 of cytochrome P-450 CYP2C9 and 1639G>A of the VKORC1 gene; On acenocoumarol requirement in Moroccan patientsF Z Smires, R Habbal, C Moreau, et al.
La Revue De Medecine Interne|March 23, 2023
[Clinical, biochemical and epidemiological features of macro-AST preceding inflammatory bowel disease diagnosis by several years]Z Nadour, B Rosenbaum, H Blons, et al.
Digestive Diseases and Sciences|November 21, 1998
Concurrent emergence of hepatitis B e antigen-negative hepatitis B virus variant and autoimmune hepatitis cured by adenine arabinoside monophosphateH Bécheur, D Valla, M A Loriot, et al.
Hepatology (Baltimore, Md.)|July 10, 1998
Hepatitis C virus persistence in human hematopoietic cells injected into SCID miceJ P Bronowicki, M A Loriot, V Thiers, et al.
Journal of Hepatology|July 1, 1990
Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis?P Marcellin, E Giostra, N Boyer, et al.
Pageof 7